PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 82 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $356,000 | +21.1% | 68,940 | -10.1% | 0.00% | – |
| Q2 2021 | $294,000 | +40.7% | 76,683 | -5.9% | 0.00% | – |
| Q1 2021 | $209,000 | -7.9% | 81,471 | -10.5% | 0.00% | – |
| Q4 2020 | $227,000 | +39.3% | 90,995 | +15.2% | 0.00% | – |
| Q3 2020 | $163,000 | -35.6% | 78,967 | -3.3% | 0.00% | – |
| Q2 2020 | $253,000 | +44.6% | 81,702 | +6.5% | 0.00% | – |
| Q1 2020 | $175,000 | +173.4% | 76,741 | +304.1% | 0.00% | – |
| Q3 2019 | $64,000 | +52.4% | 18,989 | +49.5% | 0.00% | – |
| Q1 2019 | $42,000 | -39.1% | 12,701 | -7.2% | 0.00% | – |
| Q2 2018 | $69,000 | -34.9% | 13,687 | -12.2% | 0.00% | – |
| Q1 2018 | $106,000 | +37.7% | 15,585 | +53.1% | 0.00% | – |
| Q4 2017 | $77,000 | -42.1% | 10,181 | -56.0% | 0.00% | – |
| Q3 2017 | $133,000 | +146.3% | 23,140 | +120.5% | 0.00% | – |
| Q2 2017 | $54,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |